CEVA Logistics, a global logistics and supply chain company, will be acquiring Fagioli Group, a project logistics firm.¹ As a result of the deal, CEVA will now be able to be involved in the entire logistics value chain, from early-stage development to freight forwarding and transport, to final delivery.

Last year, Fagioli—who is primarily owned by private equity firm QuattroR—reported $254 million (€216 million) in revenue and specializes in the design and execution of hauling, heavy-lift, and hoisting operations for complex project logistics.

Strengthening technical expertise and engineering talent

Meanwhile, CEVA—a heavy hitter in the freight forwarding sector—will bring on highly skilled employees from Fagioli Group, including more than 40 specialized engineers who specialize in technical ops.

As alluded to previously, given Fagioli’s experience, CEVA can now provide end-to-end solutions. This is expected to be quite helpful for business in Asia Pacific, Europe, and North America, given its partnerships with customers in those regions. The logistics firm’s also owns various fleets of equipment, ranging from gantry cranes to tower systems and barges.

“Everyone who works in project logistics knows Fagioli,” said Mathieu Friedberg, CEO of CEVA Logistics. “Their worldwide reputation and strong company values were a major factor in our decision making. Adding their technical expertise to the CEVA team, as part of the broader CMA CGM Group, would be a significant boost for our project logistics business in offering state-of-the-art, end-to-end solutions for our customers.”

Leadership perspectives on growth and global expansion

Highlighting the growth and global expansion opportunities created by the deal, Fernando Bertoni, CEO of Fagioli Group, noted that, “The arrival of CEVA Logistics would provide Fagioli with superior access-to-market capabilities, a capillary presence and local know-how in each key market around the world, as well as the necessary financial support to accelerate Fagioli’s long-term growth. In closure, my recognition goes to the hard work done by the QuattroR team over the years in repositioning Fagioli as a strong and reliable player worldwide.”

Supply chain investments extend beyond logistics M&A

In other supply chain/logistics news, Novartis recently broke ground on a 700,000-square-foot-plus flagship manufacturing hub that is expected to provide end-to-end manufacturing services.² The project—originally unveiled last month—will feature the design of a new Morrisville plant, along with a new site in Durham that will include two facilities of its own.

The services of the current Durham plant will also be grown—featuring gene therapy production as it stands—by expanding its services to include the sterile filling of biologics into syringes and vials. These new investments are expected to create 700 new Novartis jobs in the state, along with more than 3,000 indirect jobs across the supply chain by the end of the decade.

The strategic investment is part of the company’s greater mission to investment $23 billion over the next five years toward US infrastructure, while also serving as a way to strengthen the US pharma supply chain.

“It’s an exciting day for Novartis as we break ground on our new manufacturing hub, a crucial step toward delivering on our goal of producing all our key medicines for US patients domestically,” said Vas Narasimhan, CEO of Novartis. “Once complete, this new hub will become a central site for Novartis manufacturing in the US, strengthening our supply chain and underscoring our commitment to American patients.”

References

1. CEVA Logistics ‘Goes Big’ in Move to Acquire Global Project Logistics specialist Fagioli. Ceva Logistics. December 15, 2025. Accessed December 17, 2025. https://www.cevalogistics.com/en/news-and-media/newsroom/press-release/ceva-goes-big-in-move-to-acquire-global-project-logistics-specialist-fagioli

2. Saraceno N. Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring. Pharmaceutical Commerce. December 16, 2025. Accessed December 17, 2025. https://www.pharmaceuticalcommerce.com/view/novartis-23-billion-manufacturing-investment-anchors-industry-shift-toward-us-onshoring